openPR Logo
Press release

SMi Launches its 9th Annual Pre-Filled Syringes East Coast Conference

12-05-2021 01:23 PM CET | Health & Medicine

Press release from: SMi Group

Pre-Filled Syringes East Coast

Pre-Filled Syringes East Coast

After nearly two years of virtual meetings the industry looks set to meet face to face and have some really important discussions and you are invited to join them.

SMi’s 9th Annual Conference
Pre-Filled Syringes East Coast
Main Conference: April 25 - 26, 2022 | Workshops: April 27, 2022
Sheraton Boston Hotel, Boston, MA, USA
www.pfsamericas.com/openPR1

Sponsors are: SCHOTT, ZEON

Exhibitors: Owen Mumford Pharmaceutical Services, PHC Corporation, POLYPLASTICS- TOPAS, Weiss-Aug Group

Device innovations, connected delivery and regulatory guidance for advanced parenteral systems

The global pre-filled syringes market was valued at $1139.6 million in 2020 and with the rapid growth of the industry, is expected to grow at a CAGR of 8.95% up to 2027. With that in mind, the 9th annual Pre-Filled Syringes East Coast conference will bring together leading industry experts representing big pharma and device developers to discuss the key drivers accelerating the expansion of the industry.
The past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic, updates in regulations including the EU MDR and FDA guidance on bridging studies, and increasing industry acceptance of connectivity to aid the user experience. As part of SMi’s leading injectable series, the 2022 conference will provide an exclusive insight into the latest developing technologies for device design, advances in parenteral device platforms and development, insights into growing integration of digital health and deep dives into recent case studies on novel delivery systems.
This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more.

Visit the website at: www.pfsamericas.com/openPR1

Chair for 2022:
Gretchen Vandal, Sr. Director, Head of Global Regulatory Affairs – Devices and Combination Products, Takeda

Guest FDA Speaker:
• John Barr Weiner, Associate Director for Policy and Product Classification Office, Office of Combination Products FDA

Featured 2022 Speakers Include:
• Joyce Zhao, Associate Director, Combination Product, Takeda
• Suzette Roan, Associate VP and Head of Global Device Regulatory Affairs, Sanofi US
• Christine lynn lanning, Distinguished Scientist, Device Area Leader, Merck
• Heather l. Guerin, Associate Director, Regulatory Affairs – CMC, Janssen
• Tieming Ruan, Senior Director of Device Development, Alexion Pharmaceuticals
• John Schalago, Executive Director, Senior Global Program Director Regulatory Affairs, Novartis
• Gretchen Piwinski, Manager, Combination Product Laboratories, Regeneron
• Michael Song, Associate Director, Takeda
• Deep S Bhattacharya, Senior Scientist, Drug Product Development and Design, Pfizer

BENEFITS OF ATTENDING:
• Explore the latest developments in innovative technologies for device design accelerating the path to self-administration
• Assess the evolving regulatory landscape for pre-filled syringes and discuss approaches to work with regulators as guidance is updated
• Engage in panel discussions with industry leaders to navigate the accelerating digital health landscape for combination products and drug delivery systems
• Understand the landscape of delivery for novel drug products and key considerations to overcome challenges in CCI
View the full agenda and speaker line-up online: www.pfsamericas.com/openPR1

Who should Attend:
• Drug-delivery developers
• Medical Device Engineers
• Primary Packaging material designers
• Secondary packagers
• Smart device developers
• Training device developers
• Device-safety solution providers
• Drug developers
EARLY-BIRD RATES:

 BOOK BY 17th DECEMBER AND SAVE $400
 BOOK BY 31st JANUARY AND SAVE $200
 BOOK BY 28TH FEBRUARY AND SAVE $100

Registrations can be made on the event website at: www.pfsamericas.com/openPR1

POST CONFERENCE WORKSHOP A: EU MDR 2017/745 Article 117 Requirements
Workshop Leader: Theresa Jeary, Technical Specialist & Scheme Manager, BSi
08.30 - 12.30

Overview of the workshop:
The workshop is aimed to provide an introduction to the key elements of the Medical Device Regulation that Companies affected by article 117 need to consider.

Why you should attend:
• Be able to determine if Article 117 is applicable to your products
• Understand and be able to interpret the requirements of Article 117
• Understand the impacts on your marketing authorization application or post-market variation
• Gain an appreciation and understanding of the MDR Annex I, General Safety & Performance Requirements
• Understand requirements to facilitate the documentation preparation needed to obtain a NB Opinion

POST CONFERENCE WORKSHOP B: Developing User-Centric Next Generation Combination Products
Workshop Leaders: Marty Coyne, Principal & Co-Founder, Matchstick and Chris Franzese, Principal & Clinical Leader, Matchstick
13.00 - 17.00

Overview of the workshop:
This interactive workshop will explore approaches for developing innovative drug delivery device combination products offering tools for optimal device development with the user in mind. Workshop leaders will provide insights into effectives strategies for concept generation, product testing and validation for the future of device design.

Why you should attend:
• Discover innovative concept generation approaches for device development
• Understand how to utilise user feedback and experiences in early stages of development
• Walk through unique examples assessing effective testing to ensure an optimal product
• Engage in interactive discussions to assess opportunities for enhanced devices ensuring the patient is kept at the forefront

Visit the website here to find out more and to download the full agenda: www.pfsamericas.com/

Additional Contact Info:
T: +44 (0)20 7827 6088
E: rjones@smi-online.co.uk
Follow us: @SMiPharm #SMiPFSUSA
www.pfsamericas.com/openPR1

Richard Jones | Senior Marketing Executive

SMi Group Ltd
Registered & Head Office
Ground Floor, India House, 45 Curlew Street
London, SE1 2ND
Registered in England : Reg No.3779287
T: +44 (0) 20 7827 6000
DDI: +44 (0) 20 7827 6088
Fax: +44 (0) 20 7827 6089

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMi Launches its 9th Annual Pre-Filled Syringes East Coast Conference here

News-ID: 2485169 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Reg

REG - water regulation made easy
Mechanical flow restrictor from the house of Kobold Mechanical flow restrictors REG from instrumentation specialists based in Hofheim am Taunus, impress with their simple and effective functionality. Once installed, the REG limits the flow to a preset fixed value, regardless of pressure fluctuations. Due to the high quality stainless steel design, the REG is completely maintenancefree. With no auxiliary power and secure from manipulation, the REG is particularly suitable for consumer applications
Renewable Fuel Market to Show Strong Growth by 2028 | Neste Oil, REG, Cargill, A …
Latest published market study on Renewable Fuel Market provides an overview of the current market dynamics in the Renewable Fuel space, as well as what our survey respondents-all outsourcing decision-makers-predict the market will look like in 2027. The study breaks market by revenue and volume (wherever applicable) and price history to estimates size and trend analysis and identifying gaps and opportunities. Some of the players that are in coverage of
Bioliquid Heat and Power Generation Market Overview 2019-2024 | Detailed Analysi …
Bioliquid Heat and Power Generation Market Report covers the manufacturers’ data, including shipment, price, revenue, gross profit, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data. Get Sample Copy of this Report @ https://www.orianresearch.com/request-sample/1293184 Top Players
Project NMP-REG: Looking back on a successful cooperation
Phase I of the Interreg Europe project NMP-REG ends on March 31, 2019. Good reason for drawing a summary of an intensive and successful cooperation with partners from other European regions and stakeholders from North Rhine-Westphalia after a three years period. Therefore, the cluster NMWP.NRW invited to the information event „Erfolgreich in den Schlüsseltechnologien“ (Being successful in Key Enabling Technologies), which took place in Duesseldorf on March 26, 2019. The event
Bioliquid Heat and Power Generation Market In-depth Analysis By Leading Key Play …
Market Highlights The global Bioliquid Heat & Power Generation Market is expected to grow at ~ 7.60% CAGR during the forecast period. Bioliquids are fuels made from biomass for energy purposes including heating and generating power. Bioliquids have high energy density and having been used for many years. The bioliquid as a technology is well established and can be used on demand, reacting quickly to changes in demand for power. Bioliquids
NMP-REG @ 8th NRW Nano Conference
North Rhine-Westphalia’s leading role in the fields of nanotechnology and materials science is clearly demonstrated at the biennially organised NRW Nano Conference, the most important nanotechnology event in Germany. The focus of the last event, which took place in Dortmund from 21-22 November 2018, was extended from nanotechnology to the topic of “Innovations in Materials and Applications” taking into account current developments in industry and science. International keynotes and plenary